Veterinary Medicines

Parvosin ERY, emulzija za injekciju, za svinje

Authorised
  • Erysipelothrix rhusiopathiae, serotype 1 and 2, Inactivated
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Download as PDF

Product identification

Medicine name:
Parvosin ERY, emulzija za injekciju, za svinje
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 1 and 2, Inactivated
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 1 and 2, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/21-01/447
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 22/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."